These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1343450)

  • 1. The Gordon Wilson Lecture. Plasma cholesterol: atherogenesis and mortality.
    Fisher WR
    Trans Am Clin Climatol Assoc; 1993; 104():77-92; discussion 92-3. PubMed ID: 1343450
    [No Abstract]   [Full Text] [Related]  

  • 2. Type II hyperlipoproteinemia, hyperapobetalipoproteinemia, and hyperalphalipoproteinemia following renal transplantation: prevalence and precipitating factors.
    Lowry RP; Soltys G; Mangel R; Kwiterovitch P; Sniderman AD
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2229-32. PubMed ID: 3547921
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices].
    Herrmann W; Reuter W
    Z Gesamte Inn Med; 1982 Dec; 37(24):830-3. PubMed ID: 6963524
    [No Abstract]   [Full Text] [Related]  

  • 4. [Arteriosclerosis. II. Pathogenesis of dyslipoproteinemia].
    Cybulska B; Kłosiewicz-Latoszek L
    Wiad Lek; 1985 Aug; 38(15):1097-103. PubMed ID: 4072207
    [No Abstract]   [Full Text] [Related]  

  • 5. Low-density lipoprotein (LDL) receptors and the regulation of serum LDL levels.
    Vermeer BJ
    Neth J Med; 1985; 28(2):52-8. PubMed ID: 3919323
    [No Abstract]   [Full Text] [Related]  

  • 6. [Metabolism and possible mechanisms of atherogenesis induced by lipoprotein (a)].
    Krempler F
    Wien Klin Wochenschr Suppl; 1984; 151():1-12. PubMed ID: 6091345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type II hyperlipoproteinemia, hyperapobetalipoproteinemia, and hyperalphalipoproteinemia following renal transplantation: implications for atherogenic risk.
    Lowry RP; Soltys G; Peters L; Mangel R; Sniderman AD
    Transplant Proc; 1987 Aug; 19(4):3426-30. PubMed ID: 3303510
    [No Abstract]   [Full Text] [Related]  

  • 8. [LDL receptors].
    Ducobu J
    Rev Med Brux; 1990 Dec; 11(10):481-92. PubMed ID: 2293288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current theories on the role of lipoproteins of different classes in the etiology of arteriosclerosis].
    Gasilin VS; Kurdanov KhA
    Ter Arkh; 1981; 53(8):130-8. PubMed ID: 7027512
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of modification of lipoproteins and of the immune system in early atherogenesis.
    Mol MJ; Demacker PN; Stalenhoef AF
    Neth J Med; 1993 Aug; 43(1-2):83-90. PubMed ID: 8232700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis.
    Skålén K; Gustafsson M; Rydberg EK; Hultén LM; Wiklund O; Innerarity TL; Borén J
    Nature; 2002 Jun; 417(6890):750-4. PubMed ID: 12066187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular biology: a cholesterol tether.
    Staels B
    Nature; 2002 Jun; 417(6890):699-701. PubMed ID: 12066168
    [No Abstract]   [Full Text] [Related]  

  • 13. Can modification of risk factors reduce coronary heart disease?
    Grundy SM
    Cardiovasc Clin; 1983; 13(1):283-96. PubMed ID: 6336670
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of dietary treatment on the plasma levels of lipids, lipoprotein cholesterol and LDL B protein in children with type II hyperlipoproteinemia.
    Kwiterovich PO; Bachorik PS; Franklin FA; Margolis S; Georgopoulos L; Teng B; Sniderman AD
    Prog Clin Biol Res; 1985; 188():123-37. PubMed ID: 4059254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blood plasma prostaglandins and their role in disorders of lipid metabolism in ischemic heart disease caused by coronary arteriosclerosis].
    Bochkareva EV; Zykova VP; Lobova NM; Polesskiĭ VA; Gadzhanova SI
    Ter Arkh; 1980; 52(5):18-22. PubMed ID: 7404361
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of low-density lipoprotein apheresis.
    Ziajka P
    Am J Cardiol; 2005 Aug; 96(4A):67E-69E. PubMed ID: 16098847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of lipoproteins in the etiology of arteriosclerosis].
    Cybulska B; Szostak WB
    Kardiol Pol; 1981; 24(5):387-96. PubMed ID: 7021946
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical studies in a kindred with a kinetic LDL receptor mutation causing familial hypercholesterolemia.
    Bilheimer DW; East C; Grundy SM; Nora JJ
    Am J Med Genet; 1985 Nov; 22(3):593-8. PubMed ID: 4061492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of the cholesterol controversy.
    Levy RI
    Am J Med; 1983 May; 74(5A):1-4. PubMed ID: 6342382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lipoprotein(a): structure, metabolism and atherosclerotic disease].
    Postorino G; Altavilla R
    Minerva Med; 1992 Oct; 83(10):581-8. PubMed ID: 1461528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.